SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 89 filers reported holding SERES THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 2.50 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $152 | -47.9% | 64,201 | +5.2% | 0.00% | – |
| Q2 2023 | $292 | -55.2% | 61,020 | -47.0% | 0.00% | -100.0% |
| Q1 2023 | $652 | +2314.8% | 115,100 | +2228.5% | 0.00% | – |
| Q4 2022 | $27 | -100.0% | 4,943 | -43.9% | 0.00% | – |
| Q4 2021 | $73,000 | -94.8% | 8,818 | -85.8% | 0.00% | -100.0% |
| Q3 2021 | $1,404,000 | +19.5% | 62,164 | +26.1% | 0.00% | 0.0% |
| Q2 2021 | $1,175,000 | +74.9% | 49,282 | +51.0% | 0.00% | 0.0% |
| Q1 2021 | $672,000 | +147.1% | 32,641 | +193.5% | 0.00% | – |
| Q4 2020 | $272,000 | -73.9% | 11,121 | -69.8% | 0.00% | -100.0% |
| Q3 2020 | $1,042,000 | +25950.0% | 36,826 | +2539.9% | 0.00% | – |
| Q4 2019 | $4,000 | -86.2% | 1,395 | -84.7% | 0.00% | – |
| Q2 2019 | $29,000 | +123.1% | 9,100 | +601.1% | 0.00% | -100.0% |
| Q4 2017 | $13,000 | -95.1% | 1,298 | -92.2% | 0.00% | -90.9% |
| Q3 2017 | $267,000 | +403.8% | 16,678 | +280.2% | 0.01% | +175.0% |
| Q3 2016 | $53,000 | – | 4,387 | +19840.9% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 22 | -86.5% | 0.00% | – |
| Q3 2015 | $4,000 | – | 163 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 21,571,764 | $610,696,000 | 16.87% |
| RA Capital Management | 4,750,000 | $134,473,000 | 2.46% |
| ARK Investment Management | 12,293,033 | $348,016,000 | 2.06% |
| Opaleye Management Inc. | 335,312 | $9,493,000 | 1.86% |
| Sio Capital Management, LLC | 316,800 | $8,969,000 | 1.78% |
| Ikarian Capital, LLC | 762,400 | $21,585,000 | 1.56% |
| Nikko Asset Management Americas, Inc. | 5,531,670 | $152,176,000 | 1.35% |
| EAM Global Investors LLC | 121,629 | $3,443,000 | 1.26% |
| EAM Investors, LLC | 133,591 | $3,782,000 | 0.90% |
| GILDER GAGNON HOWE & CO LLC | 3,185,420 | $90,179,000 | 0.56% |